S. 1008 · 115th Congress
Therapeutic Hemp Medical Access Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
GardnerSponsor12 cosponsors · 5 D, 7 R
R
Alexander
TB
D
Baldwin
OH
R
Hatch
JI
R
Isakson
RJ
R
Johnson
ML
R
Lee
JM
D
Merkley
MW
D
Warner
RB
R
Blunt
LG
R
Graham
RW
D
Wyden
AK
D
Klobuchar8 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
What it does: CRS summary · Introduced in Senate · May 2, 2017
Therapeutic Hemp Medical Access Act of 2017
This bill amends the Controlled Substances Act (CSA):
- to add definitions for the terms "cannabidiol," "cannabidiol-rich plants," and "tetrahydrocannabinol concentration";
- to exclude cannabidiol and cannabidiol-rich plants from the definition of marijuana; and
- to remove cannabidiol and cannabidiol-rich plants from coverage under the CSA.
It also specifies that no provision of this bill prohibits or restricts the use, production, or distribution of marijuana in a state in which such activities are legal under state law.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Therapeutic Hemp Medical Access Act of 2017
Latest action (May 2, 2017): Read twice and referred to the Committee on the Judiciary.
Policy area: Crime and Law Enforcement · Origin: Senate · Introduced: May 2, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.